Skip to content

Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis

Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03259282
Acronym
GAMES
Enrollment
78
Registered
2017-08-23
Start date
2017-03-07
Completion date
2017-03-22
Last updated
2018-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoidosis

Brief summary

Evaluation of the rate of achievement of serum protein electrophoresis (PPE) in diagnosis in a retrospective cohort of patients at Rennes University Hospital

Detailed description

In 50% of cases, sarcoidosis is associated with polyclonal hypergammaglobulinemia. The other forms have a normal gamma globulin level. The level of gamma globulinemia has not yet been studied as an evolutionary predictive factor. Furthermore, there are disseminated granulomatoses sharing common characteristics with sarcoidosis, associated with Common Variable Immunodeficiency deficit (DICV) type Primary Immunodeficiency syndrome (DIP), thus occurring in hypogammaglobulinemic patients.

Interventions

BIOLOGICALAnalysis of gamma globulin

Electrophoresis of proteins

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- Patients newly diagnosed with sarcoidosis

Exclusion criteria

* Comorbidity responsible for a change in the level of gamma globulin * Other etiology of granulomatosis

Design outcomes

Primary

MeasureTime frameDescription
Study of gamma globulin level present in the blood at the time of diagnosis of sarcoidosis on disease activityDay 1Electrophoresis rates of serum proteins
Study of gamma globulin level present in the blood at the time of diagnosis of sarcoidosis on the course of the diseaseDay 1Electrophoresis rates of serum proteins

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026